Clinico-pathological study of mucormycosis in post-COVID patients at government general hospital, Nizamabad

Background: Mucormycosis is a rare, opportunistic fungal infection with high morbidity and mortality. Coronavirus disease 2019 (COVID-19) associated mucormycosis has been increasing in frequency since early 2021, particularly among patients with uncontrolled diabetes and systemic corticosteroid trea...

Full description

Bibliographic Details
Main Authors: Manisha Thavanam, Farida Begum, Seshava Puri Smitha Vadana, Nagarjuna Chary Rajarikam, Harish Swamy Dharmagadda
Format: Article
Language:English
Published: Manipal College of Medical Sciences, Pokhara 2023-02-01
Series:Asian Journal of Medical Sciences
Subjects:
Online Access:https://www.nepjol.info/index.php/AJMS/article/view/48697
_version_ 1797937055788957696
author Manisha Thavanam
Farida Begum
Seshava Puri Smitha Vadana
Nagarjuna Chary Rajarikam
Harish Swamy Dharmagadda
author_facet Manisha Thavanam
Farida Begum
Seshava Puri Smitha Vadana
Nagarjuna Chary Rajarikam
Harish Swamy Dharmagadda
author_sort Manisha Thavanam
collection DOAJ
description Background: Mucormycosis is a rare, opportunistic fungal infection with high morbidity and mortality. Coronavirus disease 2019 (COVID-19) associated mucormycosis has been increasing in frequency since early 2021, particularly among patients with uncontrolled diabetes and systemic corticosteroid treatment. Aims and Objectives: The aim of the study was to study mucormycosis occurrence in COVID-19 patients at Government General Hospital, Nizamabad – A tertiary care center and to correlate mucormycosis with comorbidities and previous treatment modalities among admitted post COVID-19 patients. Materials and Methods: Cross-sectional retrospective study was done for 3 months, from June 2021 to August 2021. Fifty suspected cases of mucormycosis specimens sent to the Department of Pathology, Government General Hospital, Nizamabad for histopathological diagnosis were considered. Clinical history and treatment details were noted. Tissues obtained were fixed in 10% formalin, routine hematoxylin and eosin (H&E) stains were done. Gomori’s methenamine silver stains were done. Results: Mucormycosis was most common in males 37 (74%) and common in the age group of 41–50 years (26%). Diabetes mellitus is the most common comorbidity (60%). The mean duration between diagnosis of COVID-19 and development of symptoms of mucor was 6–40 days. Out of 50 cases, 46 patients received steroid therapy and 39 cases were given oxygen support. Conclusion: Mucormycosis is a rapidly progressive life-threatening opportunistic infection. Post COVID-19 patients with uncontrolled diabetes are more prone to it and an important predisposing factor. Treatment with steroid therapy and oxygen support must be carefully monitored and used in a vigilant manner. Histopathological examination and clinical correlation are essential for early diagnosis and treatment.
first_indexed 2024-04-10T18:38:46Z
format Article
id doaj.art-a8b1f4b19ee74acfbcb102c9029ce5d4
institution Directory Open Access Journal
issn 2467-9100
2091-0576
language English
last_indexed 2024-04-10T18:38:46Z
publishDate 2023-02-01
publisher Manipal College of Medical Sciences, Pokhara
record_format Article
series Asian Journal of Medical Sciences
spelling doaj.art-a8b1f4b19ee74acfbcb102c9029ce5d42023-02-01T23:31:27ZengManipal College of Medical Sciences, PokharaAsian Journal of Medical Sciences2467-91002091-05762023-02-011422227https://doi.org/10.3126/ajms.v14i2.48697Clinico-pathological study of mucormycosis in post-COVID patients at government general hospital, NizamabadManisha Thavanam 0https://orcid.org/0000-0003-3137-1982Farida Begum 1https://orcid.org/0000-0002-5370-1420Seshava Puri Smitha Vadana 2https://orcid.org/0000-0002-3819-7430Nagarjuna Chary Rajarikam 3https://orcid.org/0000-0003-4297-9686Harish Swamy Dharmagadda 4https://orcid.org/0000-0001-9262-9321Postgraduate Resident, Department of Pathology, Government Medical College, Nizamabad, Telangana, India Associate Professor, Department of Pathology, Government Medical College, Nizamabad, Telangana, India Assistant Professor, Department of Pathology, Government Medical College, Nizamabad, Telangana, India Professor and Head, Department of Pathology, Government Medical College, Nizamabad, Telangana, India Assistant Professor, Department of ENT, Government Medical College, Nizamabad, Telangana, India Background: Mucormycosis is a rare, opportunistic fungal infection with high morbidity and mortality. Coronavirus disease 2019 (COVID-19) associated mucormycosis has been increasing in frequency since early 2021, particularly among patients with uncontrolled diabetes and systemic corticosteroid treatment. Aims and Objectives: The aim of the study was to study mucormycosis occurrence in COVID-19 patients at Government General Hospital, Nizamabad – A tertiary care center and to correlate mucormycosis with comorbidities and previous treatment modalities among admitted post COVID-19 patients. Materials and Methods: Cross-sectional retrospective study was done for 3 months, from June 2021 to August 2021. Fifty suspected cases of mucormycosis specimens sent to the Department of Pathology, Government General Hospital, Nizamabad for histopathological diagnosis were considered. Clinical history and treatment details were noted. Tissues obtained were fixed in 10% formalin, routine hematoxylin and eosin (H&E) stains were done. Gomori’s methenamine silver stains were done. Results: Mucormycosis was most common in males 37 (74%) and common in the age group of 41–50 years (26%). Diabetes mellitus is the most common comorbidity (60%). The mean duration between diagnosis of COVID-19 and development of symptoms of mucor was 6–40 days. Out of 50 cases, 46 patients received steroid therapy and 39 cases were given oxygen support. Conclusion: Mucormycosis is a rapidly progressive life-threatening opportunistic infection. Post COVID-19 patients with uncontrolled diabetes are more prone to it and an important predisposing factor. Treatment with steroid therapy and oxygen support must be carefully monitored and used in a vigilant manner. Histopathological examination and clinical correlation are essential for early diagnosis and treatment.https://www.nepjol.info/index.php/AJMS/article/view/48697covid-19; diabetes mellitus; immunosuppression; mucormycosis
spellingShingle Manisha Thavanam
Farida Begum
Seshava Puri Smitha Vadana
Nagarjuna Chary Rajarikam
Harish Swamy Dharmagadda
Clinico-pathological study of mucormycosis in post-COVID patients at government general hospital, Nizamabad
Asian Journal of Medical Sciences
covid-19; diabetes mellitus; immunosuppression; mucormycosis
title Clinico-pathological study of mucormycosis in post-COVID patients at government general hospital, Nizamabad
title_full Clinico-pathological study of mucormycosis in post-COVID patients at government general hospital, Nizamabad
title_fullStr Clinico-pathological study of mucormycosis in post-COVID patients at government general hospital, Nizamabad
title_full_unstemmed Clinico-pathological study of mucormycosis in post-COVID patients at government general hospital, Nizamabad
title_short Clinico-pathological study of mucormycosis in post-COVID patients at government general hospital, Nizamabad
title_sort clinico pathological study of mucormycosis in post covid patients at government general hospital nizamabad
topic covid-19; diabetes mellitus; immunosuppression; mucormycosis
url https://www.nepjol.info/index.php/AJMS/article/view/48697
work_keys_str_mv AT manishathavanam clinicopathologicalstudyofmucormycosisinpostcovidpatientsatgovernmentgeneralhospitalnizamabad
AT faridabegum clinicopathologicalstudyofmucormycosisinpostcovidpatientsatgovernmentgeneralhospitalnizamabad
AT seshavapurismithavadana clinicopathologicalstudyofmucormycosisinpostcovidpatientsatgovernmentgeneralhospitalnizamabad
AT nagarjunacharyrajarikam clinicopathologicalstudyofmucormycosisinpostcovidpatientsatgovernmentgeneralhospitalnizamabad
AT harishswamydharmagadda clinicopathologicalstudyofmucormycosisinpostcovidpatientsatgovernmentgeneralhospitalnizamabad